The 15th Philadelphia Prenatal Ultrasound and Fetal ECHO Course

Jun 7th, 2023Jun 9th, 2023
Philadelphia, PA
US
https://philapregnancycenter.com/conference-homepage
Phone:215-627-2229
This CME-approved (44 CME credits) three-day program includes ob/gyn ultrasound and two days of fetal echocardiography.
Latest in Home
The PPD group showed significant increased VMHC in the dorsolateral prefrontal cortex (DLPFC), precentral gyrus (PreCG) and parietal lobule (PL) (FDR correction q-value < 0.005).
ISMRM: Brain activity changes, birth trauma linked in postpartum PTSD
May 14, 2026
We're Covering ROKO 2026 - Live from Germany
Sponsored
We're Covering ROKO 2026 - Live from Germany
May 11, 2026
Ismrm Thumbnail
ISMRM: MRF may predict early breast cancer treatment response
May 14, 2026
OmniMRI in the context of reporting.
ISMRM: Researchers highlight advancements in MRI foundation models
May 14, 2026
More in Home
ISMRM: Brain activity changes, birth trauma linked in postpartum PTSD
By Kate Madden Yee
The findings could help gain a clearer picture of the condition's neurological underpinnings.
May 14, 2026
The PPD group showed significant increased VMHC in the dorsolateral prefrontal cortex (DLPFC), precentral gyrus (PreCG) and parietal lobule (PL) (FDR correction q-value < 0.005).
ISMRM: Insulin resistance, not hyperglycemia, stresses the aging brain
By Kate Madden Yee
The study results underscore MRI's value in identifying and tracking patients at risk of functional decline.
May 14, 2026
Ismrm Thumbnail
ISMRM: MRF may predict early breast cancer treatment response
By Amerigo Allegretto
Results shown at ISMRM 2026 suggest that MR fingerprinting could help in predicting early response to breast cancer treatment.
May 14, 2026
Ismrm Thumbnail
ISMRM: Researchers highlight advancements in MRI foundation models
By Liz Carey
Standardization is key to effective large-scale studies.
May 14, 2026
OmniMRI in the context of reporting.
ISMRM: DWI kurtosis approach predicts breast cancer treatment response
By Amerigo Allegretto
A DWI approach using diffusion kurtosis showed success in predicting early treatment response in breast cancer patients.
May 13, 2026
Ismrm Thumbnail
ISMRM: F-18 PSMA-1007 outperforms Ga-68 PSMA-11 at low PSA levels
By Will Morton
Significantly higher detection rates observed with F-18 PSMA-1007 at low PSA levels support its use as the preferred tracer.
May 13, 2026
Cape Town
ISMRM: 3D amplified MRI reveals age-related drop in brain pulsatility
By Kate Madden Yee
Brain pulsatility reflects cerebrovascular health, which makes it important to assess, according to study results shared at ISMRM 2026.
May 13, 2026
Representative 3D displacement maps of one subject (female, 24 years old) derived from aMRI. The top row shows the coronal, sagittal, and axial slices of a structural aMRI magnitude image for morphological context, while the bottom row shows displacement fields overlaid; greater pulsatility during the cardiac cycle is seen in areas surrounding the brainstem and cerebrospinal filled regions.
ISMRM: MRI, MRS show metabolic gains from obesity lifestyle intervention
By Kate Madden Yee
MR techniques reveal how exercising can improve metabolic measures in obese patients, suggest findings presented at ISMRM 2026.
May 13, 2026
Ismrm Thumbnail
ISMRM: Kirsten Donald on using MRI to improve children's lives
By Kate Madden Yee
Donald delivered the meeting's Lauterbur Lecture on the topic of MRI insights into child neurodevelopment.
May 13, 2026
Kirsten Donald, MBChB, PhD
ISMRM: Maruf Adewole shares how MRI, AI can expand global care
By Amerigo Allegretto
Maruf Adewole, PhD, at ISMRM 2026 shares insights on expanding MRI in global health with the help of AI.
May 13, 2026
Maruf Adewole, PhD
ISMRM: Incoming ISMRM president reflects on time in Cape Town
By Amerigo Allegretto
Incoming ISMRM president Petra Hüppi, MD, talks with AuntMinnie about her time in Cape Town and what research she is leading.
May 13, 2026
Petra Hüppi, MD, will assume her role as ISMRM president at the end of the society's 2026 meeting in Cape Town.
ISMRM: DMI detects treatment response in patients with high-grade gliomas
By Will Morton
Deuterium is a stable, nontoxic isotope used to label glucose, which is then administered as an oral imaging agent.
May 13, 2026
Representative DMI data from a patient with a high-grade glioma. DMI ratio maps pre- and post-treatment show spatial metabolic changes. Deuterium spectra from the tumor and contralateral NABP demonstrate metabolic differences and therapeutic effects.
Page 1 of 224
Next Page